Shire Development, LLC v. Mylan Pharmaceuticals Inc.

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ SHIRE DEVELOPMENT, LLC, SHIRE PHARMACEUTICAL DEVELOPMENT, INC., COSMO TECHNOLOGIES LIMITED, NOGRA PHARMA LIMITED, Plaintiffs-Appellants v. MYLAN PHARMACEUTICALS INC., MYLAN, INC., Defendants-Appellees ______________________ 2017-2268 ______________________ Appeal from the United States District Court for the Middle District of Florida in No. 8:12-cv-01190-CEH-AEP, Judge Charlene Edwards Honeywell. ______________________ JUDGMENT ______________________ ELIZABETH MURPHY, Haug Partners LLP, New York, NY, argued for plaintiffs-appellants. Also represented by EDGAR HAUG, ERIKA SELLI. DEEPRO MUKERJEE, Alston & Bird LLP, New York, NY, argued for defendants-appellees. Also represented by LANCE SODERSTROM. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (O’MALLEY, WALLACH, and HUGHES, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT April 6, 2018 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court